CLINICAL_TRIALS
trial_result
· 2016-12-01
Clinical Trial Update: Intranasal SB-705498 in Non-allergic Rhinitis Patients [Phase 2]
Summary
A Phase 2 clinical trial evaluating intranasal SB-705498 for non-allergic rhinitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Rhinitis | Phase 2 | Status: COMPLETED